Coming soon

Replay coming soon

On demand

60min

Antibody-drug conjugates: Using IP and R&D trends to inform innovation

Originally aired on
November 16, 2023 1:00 PM
EST
Presented in
November 16, 2023 1:00 PM
EST
EST

Registration is closed. The webinar recording will be viewable in 48 hours.

Antibody-drug conjugates (ADCs) are among the most promising drug classes in oncology. The ADC research landscape is rapidly evolving, driven by advancements in antibody engineering, linker technology, payload development and diversification, and more. These new innovations are reshaping the promise of ADCs.. However, they also present challenges for innovators and drug developers seeking to understand the complex and competitive intellectual property (IP) landscape.

In this webinar, experts will explore the latest trends in ADC innovation and the complications of understanding the IP landscape in this area. They will highlight the critical importance of staying up to date with evolving R&D trends and patent filings to determine freedom to operate, protect complex innovations, and maximize ROI. 

What you will learn

  • The evolving global research and IP landscape of antibody-drug conjugates.   
  • Unique challenges of developing ADC therapeutics.  
  • The competitive landscape and complex patent claims for related technologies. 
  • Strategies for a comprehensive IP search to inform investment and protect your innovations.  
  • Insights into how CAS content and solutions can enable innovators and IP professionals.

Speakers

Janet Sasso

Information Scientist, CAS

Natalia Nekrasova

IP Search Analyst, CAS

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.